Rivaroxaban 10/15/20 Adco 10 mg, 15 mg, 20 mg Tablets
PDF Leaflet Revision Date: 23 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of VTE and treatment of DVT/PE.
Dosage (summary)
10 mg once daily for VTE prevention; 15 mg twice daily for DVT/PE treatment.
Special Populations
- Hepatic impairment
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Strong CYP3A4 inhibitors
- Other anticoagulants
Contraindications
- Active bleeding
- Severe hepatic disease
- Hypersensitivity
Common side effects
- Bleeding
- Dizziness
- Headache
Counselling Points
- Take with food (15 mg and 20 mg)
- Avoid pregnancy
- Report any signs of bleeding
Serious warnings
- Increased bleeding risk
- Monitor renal function
Important Disclaimer
The Rivaroxaban 10/15/20 Adco 10 mg, 15 mg, 20 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
